Anbio Biotechnology (NNNN) Retained Earnings (2023 - 2025)

Anbio Biotechnology's Retained Earnings history runs 3 years deep, the most recent figure standing at $23.6 million for Q4 2025.

• In Q4 2025, Retained Earnings rose 37.29% year-over-year to $23.6 million; the TTM figure through Dec 2025 stood at $23.6 million (up 37.29% YoY), while the FY2025 annual figure was $23.6 million, up 37.29% from the prior year.
• Retained Earnings was $23.6 million for Q4 2025 at Anbio Biotechnology, down from $20971.4 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $20971.4 billion in Q2 2025 to a low of $14.8 million in Q4 2023.
• Historically, Retained Earnings has averaged $5242.9 billion across 3 years, with a median of $20.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings advanced 16.03% in 2024, then jumped 37.29% in 2025.
• A 3-year view of Retained Earnings shows it stood at $14.8 million in 2023, then gained by 16.03% to $17.2 million in 2024, then soared by 37.29% to $23.6 million in 2025.
• The last three Retained Earnings figures came in at $23.6 million (Q4 2025), $20971.4 billion (Q2 2025), and $17.2 million (Q4 2024), per Business Quant data.